Midlothian Laboratories is categorized under Drug Brokers in Montgomery, AL and active since 2011.
Midlothian Laboratories was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Drug Brokers business, which does work in the B2B market, and is classified as a Drug Brokers, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Bryce Harvey at the company’s single location by writing to 780 Industrial Park Boulevard C, Montgomery, Alabama AL 36117 or by phoning (334) 288-8661. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Midlothian Laboratories |
| Contact Person: | Bryce Harvey |
| Address: | 780 Industrial Park Boulevard C, Montgomery, Alabama 36117 |
| Phone Number: | (334) 288-8661 |
| Website Address: | metricsinc.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Drug Brokers |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Midlothian Laboratories was started in 2011 to provide professional Drug Brokers under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bryce Harvey for inquiries that concern Midlothian Laboratories by calling the company number (334) 288-8661, as your correspondence is most welcome. Additionally, the physical location of the single location of Midlothian Laboratories can be found at the coordinates 32.377364,-86.110965 as well as the street address 780 Industrial Park Boulevard C in Montgomery, Alabama 36117.
For its online presence, you may visit Midlothian Laboratories’s website at metricsinc.com and engage with its social media outlets through on Twitter and on Facebook.